Compare OPXS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | STRO |
|---|---|---|
| Founded | 1987 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.0M | 94.9M |
| IPO Year | N/A | 2018 |
| Metric | OPXS | STRO |
|---|---|---|
| Price | $14.28 | $9.73 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.67 |
| AVG Volume (30 Days) | 33.3K | ★ 110.8K |
| Earning Date | 12-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.32 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | $39,481,000.00 | ★ $105,646,000.00 |
| Revenue This Year | N/A | $62.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.43 | ★ N/A |
| Revenue Growth | ★ 21.00 | N/A |
| 52 Week Low | $5.36 | $5.23 |
| 52 Week High | $17.76 | $24.80 |
| Indicator | OPXS | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 88.38 |
| Support Level | $13.09 | $7.88 |
| Resistance Level | $15.44 | $9.38 |
| Average True Range (ATR) | 0.82 | 0.63 |
| MACD | 0.14 | 0.73 |
| Stochastic Oscillator | 93.26 | 97.12 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.